Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Objective: Pregnancy has frequently been referred to as a time of emotional well-being for patients. However, systematic data about the risk for relapse of depression during pregnancy are sparse.
Method: We completed a longitudinal cohort study of thirty-two (N = 32) women with histories of depression who were euthymic at conception and who either discontinued or attempted to discontinue antidepressant therapy proximate to conception. Subjects were prospectively followed across pregnancy once per trimester using structured clinical interviews. Rates of relapse and time to relapse were examined. Factors distinguishing the population with respect to risk for relapse including demographic characteristics and illness history were also examined.
Results: Seventy-five percent (N = 24) of patients relapsed during pregnancy. The majority of relapses (79%, N = 19) occurred in the first trimester, and relapse was more prevalent in women with histories of more chronic depression.
Conclusions: Pregnancy is not “protective” with respect to risk for relapse of depression. Careful treatment planning is necessary for those women on antidepressants who plan to conceive or who become pregnant.
- Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study
Archives of Women’s Mental Health
Volume 7, Issue 4 , pp 217-221
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Keywords: Pregnancy; antidepressants; depression; relapse; medication.
- Industry Sectors
- Author Affiliations
- A1. Perinatal and Reproductive Psychiatry Clinical Research Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.A.
- A3. Mood Disorders Research Program, University of California, Los Angeles, CA, U.S.A.
- A2. Pregnancy and Postpartum Mood Disorders Program, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, U.S.A.
- A4. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, U.S.A.